Does DURVALUMAB Cause Pneumonitis? 827 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 827 reports of Pneumonitis have been filed in association with DURVALUMAB (IMFINZI). This represents 4.8% of all adverse event reports for DURVALUMAB.
827
Reports of Pneumonitis with DURVALUMAB
4.8%
of all DURVALUMAB reports
221
Deaths
333
Hospitalizations
How Dangerous Is Pneumonitis From DURVALUMAB?
Of the 827 reports, 221 (26.7%) resulted in death, 333 (40.3%) required hospitalization, and 98 (11.9%) were considered life-threatening.
Is Pneumonitis Listed in the Official Label?
Yes, Pneumonitis is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
Fatigue (367)
What Other Drugs Cause Pneumonitis?
NIVOLUMAB (2,076)
PEMBROLIZUMAB (1,933)
METHOTREXATE (1,188)
PACLITAXEL (1,110)
CARBOPLATIN (975)
EVEROLIMUS (919)
IPILIMUMAB (891)
ATEZOLIZUMAB (842)
RITUXIMAB (747)
CYCLOPHOSPHAMIDE (725)
Which DURVALUMAB Alternatives Have Lower Pneumonitis Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE